Insights

In life sciences, where science speaks every language, translation is never just about words. Every term, phrase, and abbreviation must carry the precise scientific meaning intended by its author, because even the smallest linguistic slip can have serious regulatory or safety consequences. That’s why subject matter experts in life sciences translation play such a crucial role. While linguists ensure linguistic fluency and cultural accuracy, subject matter experts (SMEs) provide deep scientific and technical insight, supporting linguists to deliver translations that are not only precise but also compliant with global healthcare standards. At Avantpage Life Sciences, SMEs are the quiet but powerful champions ensuring that complex, regulated content reaches global audiences safely, clearly, and confidently. A subject matter expert is a professional with advanced knowledge in a specialised scientific field, such as, for example, pharmacology, biotechnology, clinical research, or medical device engineering. In life sciences translation, SMEs collaborate with linguists, project managers, and quality reviewers to interpret technical concepts, clarify context, and validate terminology.  While linguists master the target language, SMEs master the science behind the language. Together, they form a team that ensures the translation is scientifically sound, regulatory compliant, and linguistically precise.  For example, when translating a clinical trial protocol, an SME ensures that critical terminology (such as dosing schedules or endpoints) is correctly understood and translated. In the case of device labelling, the SME confirms that every instruction is medically accurate and aligned with safety regulations.  Life sciences content is full of complex terminology and strict regulatory language. From pharmacovigilance reports to patient-information leaflets, accuracy is non-negotiable. SMEs validate scientific terms, abbreviations, and compliance-related wording to ensure that each translated document meets the expectations of authorities such as the EMA, FDA or MHRA.  This alignment between language and regulation reduces risk and builds confidence that translations are ready for submission, publication or market release.  Even experienced translators can encounter ambiguous scientific phrases or emerging technical concepts. SMEs provide the background knowledge and domain understanding that help linguists interpret such challenges accurately.  For example, a single term like culture medium might have a distinct meaning in microbiology compared with biotechnology. The SME ensures the right contextual interpretation every time, enabling linguists to maintain precision and consistency.  Across multiple markets, products and regulatory documents, maintaining consistent terminology is essential. SMEs help build and refine term bases and glossaries that serve as shared reference tools for linguists, editors and clients.  This process ensures that translations remain uniform across all deliverables — from labelling and training manuals to e-learning modules and submissions — reinforcing brand integrity and compliance.  The life sciences industry leaves no room for error. A mistranslation could delay a product launch or cause confusion among healthcare professionals and patients. SMEs add an essential layer of review that protects against such risks, confirming that the scientific intent of the source text is preserved in every language.  By combining linguistic skill with subject expertise, the translation gains both clarity and credibility, two critical components of successful global communication.  When SMEs are involved early in a project, potential terminology or contextual issues can be identified before translation begins. This proactive approach prevents costly revisions, accelerates turnaround times, and ensures smoother collaboration between linguists, reviewers and clients.  At Avantpage Life Sciences, we integrate SMEs seamlessly into our translation workflows to guarantee scientific accuracy and regulatory compliance at every step.  Here’s how that partnership works in practice:  This structured life sciences translation workflow ensures that linguists and SMEs work as one cohesive unit, producing translations that are as clear as they are compliant.  The partnership between linguists and SMEs is built on mutual respect and collaboration. Linguists rely on SMEs for technical validation, while SMEs depend on linguists to ensure clarity and cultural fluency.  Together, they:  By combining linguistic skill and subject expertise, they transform technical information into communication that supports patient safety, research integrity and regulatory success.  In our sector, quality is defined by more than just linguistic correctness — it’s about trust. We know that life sciences clients operate in a world where a single mistranslation can delay approvals, impact safety, or undermine credibility. 

That’s why our translation processes are designed around collaboration between linguists, project managers and subject matter experts in life sciences translation.
Our translation projects benefit from:  Whether translating regulatory submissions, clinical documents, or patient materials, our SME-supported approach ensures accuracy, consistency and compliance across all markets.  Subject matter experts are the silent champions of life sciences translation. Their work happens behind the scenes, but its impact is visible in every compliant, accurate and trustworthy translation that reaches healthcare professionals, regulators and patients worldwide.  By supporting linguists with scientific insight and contextual clarity, SMEs transform the translation process into a partnership; one that ensures each word upholds the integrity of the science it represents.  At Avantpage Life Sciences, we believe that collaboration between linguists and subject matter experts is the foundation of translation excellence.  Ready to achieve greater accuracy and compliance in your life sciences translations? 
Discover how our SME-supported workflows can help your organisation communicate with confidence. Let's start the conversation!  

Each October, Breast Cancer Awareness Month unites people across the world in a shared mission: to promote early detection, innovation, and access to care. Yet, true awareness goes beyond pink ribbons and campaigns. It means ensuring that every individual, regardless of language or background, can understand and access essential health information.  That’s why breast cancer awareness in life sciences plays such a vital role. When scientific discovery, translation, and accessibility come together, awareness becomes equitable and care becomes truly global. According to the World Health Organization (WHO), breast cancer is one of the most common cancers worldwide, with approximately 2.3 million new diagnoses and 670,000 deaths annually. Projections suggest that by 2050, new cases could rise to 3.2 million per year, with deaths increasing to 1.1 million annually, disproportionately affecting countries with lower Human Development Index (HDI) scores. These figures highlight that early detection and access to understandable, culturally relevant health information are critical for improving outcomes and reducing disparities globally.  This year’s campaign theme, “Every Story Is Unique, Every Journey Matters", underlines the need for personal, inclusive communication. Patients who understand their condition and care pathway are more likely to seek help early, adhere to treatment, and feel empowered in their healthcare journey (WHO Advocacy Toolkit, 2025).  Yet millions face barriers due to limited health literacy, language differences, and cultural misunderstandings. Integrating translation and accessibility into every stage of the healthcare experience is crucial to advancing breast cancer awareness in life sciences.  Before breast cancer awareness can translate into action, it’s important to recognise the obstacles that prevent information from reaching everyone equally. These challenges span language, culture, literacy, and technology, and understanding them is the first step toward truly inclusive communication. Addressing these barriers requires collaboration between life sciences organisations, translators, and public health experts to ensure that awareness is accessible, accurate, and culturally appropriate.  By combining research, technology, and communication to improve health equity, the life sciences sector is uniquely positioned to break down these barriers.  Translation bridges the gap between research and real life. In breast cancer communication, accurate, localised translation helps ensure that patients, caregivers, and clinicians understand vital information: from diagnostic instructions to treatment options.  High-quality medical translation improves compliance, reduces anxiety, and empowers patients to make informed decisions about their health.  Digital health tools, mobile apps, and AI-driven diagnostics are expanding screening access. Yet, their impact depends on accessibility. Interfaces, instructions, and alerts must be translated and localised for global users.  Innovations like “Breamy”, an augmented reality app that helps visualise treatment outcomes, show how technology and communication together improve engagement (arXiv study).  When these tools are multilingual and culturally adapted, they can transform breast cancer care.  Clinical trials are the foundation of innovation in oncology. But many underrepresented populations remain excluded because study materials, consent forms, and recruitment materials are only available in a few languages.  By investing in life sciences translation and inclusive patient engagement, researchers can improve recruitment diversity and ensure that results represent global populations.  Trust is built on understanding. Translating clinical and educational materials into clear, patient-friendly language increases adherence and fosters open dialogue between patients and providers.  This is particularly important in oncology, where treatment plans are complex and emotionally charged. Accessible communication ensures that awareness leads to action, and ultimately, to better outcomes.  Raising awareness effectively requires thoughtful action and inclusive communication strategies. By taking deliberate steps, organisations can ensure that critical information reaches diverse communities and inspires meaningful engagement.  At Avantpage Life Sciences, we believe that medical innovation must go hand in hand with communication equity. We help organisations make this a reality by combining linguistic expertise with life sciences innovation to ensure healthcare and scientific content is understandable, accurate, and accessible in every language, communicated clearly, inclusively, and compassionately.  Through these capabilities, we help clients raise awareness across borders and barriers, advancing breast cancer awareness in life sciences with empathy and precision.  Breast Cancer Awareness Month is not only a global campaign, but also a reminder that awareness without accessibility leaves people behind. The future of healthcare depends on bridging the gap between innovation and understanding.  By combining translation, technology, and compassion, the life sciences industry can ensure that every person — regardless of language, culture, or geography — has equal access to life-saving information.  At Avantpage Life Sciences, we’re proud to help clients make their communication truly inclusive. If your organisation is developing oncology research, digital tools, or global awareness campaigns, we’d love to collaborate.  Get in touch to explore how translation and innovation can work together to advance health equity worldwide.